New Drug Approvals Archive - March 2003
Date of Approval: March 13, 2003
Fuzeon (enfuvirtide) is a fusion inhibitor used in combination with other medicines to treat HIV infection.
Femring (estradiol acetate) Vaginal Ring
Date of Approval: March 20, 2003
Femring (estradiol acetate) is a vaginal estrogen product in the form of a flexible, self-inserted ring. Femring is indicated to treat both the hot flushes and vaginal symptoms associated with menopause.
Somavert (pegvisomant) for Injection
Date of Approval: March 25, 2003
Somavert (pegvisomant) is a growth hormone receptor antagonist indicated for the treatment of acromegaly.
Emend (aprepitant) Capsules
Date of Approval: March 27, 2003
Emend (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist used in combination with other antiemetic agents to prevent and control acute and delayed nausea and vomiting associated with chemotherapy.
Patient Population Altered: August 28, 2015